GlucoTrack Inc. Logo

GlucoTrack Inc. (GCTK)

NASDAQ

Currency in USD
2.05
+0.34 (+19.88%)

Closed

Oct 28, 2026

Day's Range

1.80
2.50

52 wk Range

0.7460
225.00

Overview - GCTK - GlucoTrack Inc.

Key Statistics

Valuation

Enterprise Value

1.11M

P/E (Trailing)

‪0.07‬

PEG Ratio

‪-0.00076‬

Price / Book

‪-1.18‬

EV / EBITDA

‪-0.07‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪0.00%‬

Return on Assets

‪-164.44%‬

Return on Equity

‪-620.62%‬

Ownership

Shares Outstanding

6.55M

Float

636.27K

Short % of Shares Outstanding

‪12.00%‬

Held by Insiders

‪3.29%‬

Held by Institutions

‪5.19%‬

Price stats

Beta

‪0.72‬

50-Day Avg

‪5.03‬

200-Day Avg

‪23.29‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Latest News - GCTK - GlucoTrack Inc.

News & Analysis

View all news

Market Cap - GCTK - GlucoTrack Inc.

Peers - GCTK - GlucoTrack Inc.

Peer Comparison

Compared with companies in Medical Devices listed on NASDAQ.

Profile Summary - GCTK - GlucoTrack Inc.

About

GlucoTrack Inc. is a medical technology company focused on diabetes monitoring solutions. GlucoTrack Inc. develops devices and systems designed to measure blood glucose levels for people living with diabetes, with an emphasis on continuous monitoring and reduced reliance on traditional finger-stick testing. Its…

SectorHealthcare
IndustryMedical Devices
Employees15
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.